I too am fed up with windows and switched to Mac. I have ACT Premium 2012 on my pc and Parallels on my Mac. Is there a process for migrating my copy of ACT to my Mac? Thx, Art Report Inappropriate Content. Message 4 of 6 (1,350 Views) Reply. 1 Kudo Highlighted. Looking for a CRM for Mac? CRM contains all the aforementioned features and is a viable choice for Mac users looking to get a proven CRM system that doesn’t lack in any department. It is flexible and integrates with hundreds of third-party applications including Google Contacts, Zendesk and FreshBooks using Act! I don't anticipate a native version of the ACT! Program for the MAC happening anytime soonif at all. Such a version would be a completely different version of the ACT! Program because the present ACT! Program is built on the Microsoft.NET Framwork and uses the Microsoft SQL server for the database and both require the Windows operating system. Although there are no plans to release a Mac based TaxAct download product at this time, Mac users can use the online version of TaxAct (web-based tax preparation) to do their taxes. Please review the System Requirements for Mac systems using TaxAct online.
Act 1194- Regulates how drugs can be put on the MAC list as well as requires the MAC lists be made available to pharmacies. The act also requires that necessary updates be performed on the MAC list every 7 days. It also creates an appeals process for pharmacies to dispute MAC price billing with PBMs. (Act signed into Law April 12, 2013)
California:
A.B. 627: This bill would exempt certain contracts governing medicine and medical supplies that are provided to injured employees in workers' compensation cases from certain requirements. It also requires PBMs that reimburse contracting pharmacies to identify data sources used to determine the MAC for drugs on MAC lists. They also need to provide an appeals process and the most up-to-date MAC lists they have. Only certain drugs can be included on the lists. Signed into law on July 13, 2015.
Hawaii:
H.B. 252: Establishes requirements for PBMs that reimburse contracting pharmacies for drugs on MAC basis. PBMs must have a clearly defined process for contracting pharmacies to appeal the MAC for drugs on MAC lists, and establish requirements for that process. Signed into law July 2, 2015.
Iowa:
HF 2297: Regulates PBM management of Maximum Allowable Costs. Among the various provisions is a requirement for the PBM to include in its contract information regarding which of the national compendia is used to obtain pricing data used in the calculation of the maximum reimbursement amount pricing and a process to allow a pharmacy to comment on, contest, or appeal the maximum reimbursement amount rates or maximum reimbursement amount list. (Signed into Law March 14, 2014)
Kansas:
S.B. 103: This bill says PBMs shall not put drugs on MAC lists unless they meet certain conditions, they shall provide the sources used to determine the MAC price, MAC lists shall be reviewed and updated every seven days, and there will be an appeals process laid out. Signed into law on March 23, 2016.
Kentucky:
S.B. 107 - Requires PBMs to identify the sources used for their drug price data as well give the contracted pharmacies the actual cost MAC for each drug. Additionally it requires reviews and adjustments to the MAC list for every drug every 14 days. (Signed into Law March 22, 2013)
S.B. 117 - Requires PBMs to obtain a license, defines MAC, provides for an appeals process, price updates, and administrative regulations, requires review of MAC every seven days, provides for fees to cover enforcement costs. Signed into law April 9, 2016.
Louisiana:
S,B. 410 - Requires that PBMs make their MACs available to all pharmacies that are subject to the MAC list, no longer than seven days from a change in the MAC setting methodology or in the variable involved in the methodology. (Effective August 1, 2014)
Maine:
L.D. 1150: Requires that drugs meet certain conditions for PBMs to include them on the MAC list. Stipulates PBMs shall remove or modify MACs for drugs as necessary, and that they shall disclose to pharmacies and carriers the methods and sources used to establish MACs. Also, every seven days, MACs shall be disclosed. Signed into law on April 11, 2016.
Maryland:
S.B. 952 and H.B. 793 - Requires PBMs to disclose pricing methodology to pharmacies, specifying that the PBMs must identify national drug pricing compendia or other source used to obtain the drug price and the methodology used to calculate MAC. PBMS must also establish a process by which network pharmacies can appeal a MAC. (Signed into law May 5, 2014).
New Mexico:
H.B. 126 This legislation would provide a reasonable degree of transparency over how MAC pricing is determined and reported. The legislation also takes additional steps to reform PBM activities in New Mexico. This law will help preserve patient access to prescription drugs and better protect New Mexico’s small business community pharmacies from being reimbursed at a financial loss. It will establish guidelines and notice provisions for Maximum Allowable Cost for drugs and a system for challenging the MAC pricing. (Signed into law by the Governor March 5th, 2014).
North Dakota:
H.B. 1363 - Requires the PBMs to every year divulge the market-based source utilized to determine MAC and update the pricing information every seven calender days. Also ensures that the MAC prices are not set below market-based sources available for purchases without limitations by pharmacy providers. (Signed into Law April 12, 2013) - See our letter in support of H.B. 1363
Oklahoma:
H.B. 2100 - Regulates the conduct and transparency of PBMs and specifies that they must reveal the basis of the methodology and sources used to determine MACs and also must update and share new MAC prices with their pharmacies every seven days. PBMs must also provide a reasonable appeals process for pharmacies. (Signed into law May 12, 2014)
Ohio:
H.B. 64 - Language incorporated into budget. Requires PBMs to be licensed as third party administrators by the Ohio Department of Insurance, give DOI the power to revoke their licenses or fine them if needed. PBMs must also supply a list of the sources used to determine MAC prices, update and implement MAC pricing information at least every seven days, and provide an appeals process. Only certain drugs that meet conditions can be added to the MAC list. Signed into law on June 30, 2015.
Oregon:
H.B. 2123 - Requires PBMs to disclose to pharmacies the sources used to determine the MAC pricing at the start of each contract and upon each subsequent renewal of the contract. PBMs also can no longer include the dispensing fee in the calculation of the MAC. (Signed into Law July 1, 2013)
Pennsylvania:
H.B. 946 - Requires PBMs to be registered, sets up auditing procedures for pharmacies, sets transparency guidelines for MAC and prescription drugs reimbursements. Signed into law on November 22, 2016.
Tennessee:
H.B. 1554 - Regulates the use of MAC lists by PBMs and other covered entities, requiring them to provide to their contracted pharmacies the methdology and sources used to determine the MAC for multi-source generic drugs. In addition, PBMs are prohibited from setting MACs at an amount lower than the amount found in the source used by the PBM to set the cost. (effective January 1, 2015)
S.B. 1789- Allows a pharmacy to designate a pharmacy services administrative organization to file and handle an appeal challenging the maximum allowable cost for a particular drug or medical product or device on behalf of the pharmacy. Signed into law March 23, 2016.
Texas:
S.B. 1106 - This law regulates what drugs can be placed on the MAC cost list as well as spells out the frequency for how frequently the MAC information must be updated to reflect any modification in MAC pricing. Specifies information that must be given to pharmacies when entering or renewing contracts as well as creates an appeals process for pharmacies to contest MAC reimbursement rates. (Signed into Law June 14, 2013)
South Carolina:
S. 849: Provides guidelines to the maximum allowable cost reimbursements for generic drugs paid by PBMs to pharmacists. Drugs must meet certain conditions to be on the MAC list, PBMs must make sources used to determine MAC prices available to pharmacies, and they must establish an appeals process. Signed into law on May 2, 2016.
Utah:
H.B. 113 - This law regulates certain reimbursement practices of Pharmacy Benefits Managers including the Maximum Allowable Cost as well as appeal rights for Pharmacies. The MAC may be determined be determined by using comparable and current data on drug prices obtained from multiple nationally recognized, comprehensive data sources, including wholesalers, drug file vendors, and pharmaceutical manufacturers for drugs that are available for purchase by pharmacies in the state. The PBM is however responsible for disclosing in their contract with a pharmacy the national drug pricing compendia and other sources used to obtain the drug prices, as well as review and make necessary changes to the MAC list once per week. (Signed into Law March 31, 2014)
Washington:
SB 6137: This law requires PBMs to register with the Department of Revenue, imposes limits on audits of pharmacies by PBMs and other entities, places restrictions on the use of MAC pricing and includes appeals processes for pharmacy audits and MAC pricing. Would regulate how Pharmacy Benefit Managers operate in the State broadly as well as outlines specifics including how audits are to be conducted and take place as well as details surrounding the application of a Maximum Allowable Cost list. A PBM would be required to make available to each network pharmacy at the beginning of the term of a contract, and upon renewal of a contract, the sources utilized to determine the MAC pricing of the PBM. Additionally a PBM is mandated to update each list every seven business days and make said updated lists available to network pharmacies. (Signed into law by Gov. Jay Inslee (D) on April 3, 2014)
The global pandemic has heightened the importance of home to all of us, as well as the critical role we play in supporting multifamily housing for millions of families across the country. In response to this national crisis, Congress has enacted legislation that places certain legal obligations on multifamily borrowers with federally backed mortgages, including those purchased and/or securitized by Freddie Mac.
These interventions are unprecedented, as are hundreds of additional state and local laws affecting multifamily properties that have been enacted throughout the country to address this unique crisis. As for provisions that directly affect borrowers, there are two sections of the CARES Act that you should be aware of: a national eviction moratorium (section 4024) and separate provisions that govern our COVID-19 forbearance agreements (section 4023).
As we reach the end of the national eviction moratorium in the CARES Act, we all need to remind ourselves of the responsibilities we still have under the law:
National Eviction Moratorium
The CARES Act eviction moratorium that applies to all Freddie Mac Multifamily loans ended on July 25, unless Congress takes further action. However, there are certain responsibilities under the Act, and through the Freddie Mac forbearance program, that will continue:
- Any notice to vacate related to nonpayment of rent requires a 30-day notice, which may not be issued prior to the end of the moratorium on July 25.
- In addition, borrowers may not charge tenants fees or penalties due to nonpayment of rent for the period covered by the moratorium.
Borrowers should be aware that failure to abide by these provisions of federal law can trigger a default under Freddie Mac’s loan documents.
Additional Requirements for Loans with Forbearance Agreements
For loans with a current Freddie Mac COVID-19 related forbearance agreement, certain tenant protections extend beyond the expiration of the nationwide eviction moratorium. Other additional protections associated with our revised program may also apply:
- Borrowers may not evict, give notice of, or start an eviction of a renter for nonpayment during the forbearance period.
- Borrowers cannot charge late fees, penalties, or other charges related to tenant nonpayment of rent during the forbearance period, as required by the CARES Act. This protection was extended to the repayment period as well, for forbearance agreements and supplemental forbearance agreements entered into after June 29.
- As of June 29, borrowers entering into new or supplemental forbearance agreements must provide flexibility in repayment of back rent, allowing for it to be paid over a period of time and not in a lump sum.
- Additionally, borrowers entering into new forbearance agreements or supplemental forbearance agreements must provide 30-days’ notice to tenants prior to any eviction taking place during the repayment period.
- Renters need not show COVID-19 related hardship to be eligible for any of the protections listed above.
Borrowers who do not comply with the terms of our forbearance agreements or loan documents, which include a requirement to comply with all laws having jurisdiction over the borrower’s property (for example, the CARES Act), are in default and the borrower may face lender enforcement action.
State and Local Eviction Protections
Act For Macintosh
While the CARES Act and Freddie Mac forbearance program apply nationally, there may also be tenant protections in place at the state and/or local level. Borrowers are encouraged to consult their legal representative about laws that may apply to them.
Renter Resources
Tax Act For Mac
To help tenants struggling to pay rent, we have a free financial hotline and other information available to renters.
Act Summaries For Macbeth
We thank all our lenders and borrowers for rising to the challenge of this pandemic and their unwavering partnership in making home possible. We appreciate your efforts to abide by these rules of the road and understand you may have questions related to how these requirements might affect your unique circumstances. Borrowers with questions on this topic are strongly encouraged to reach out to their lenders for support.
- Feedback
Have a comment or question? Email us to let us know what's on your mind.